Rottendorf Pharma Enhances Validation with ValGenesis VLMS
ValGenesis, Inc., a leader in the realm of enterprise validation lifecycle management systems (VLMS), has been selected by Rottendorf Pharma to revolutionize their digital validation processes. This notable choice marks a significant milestone in Rottendorf Pharma's commitment to modernization and efficiency.
Understanding Rottendorf Pharma's Legacy
With a robust history of over 95 years, Rottendorf Pharma stands out as a premier contract development and manufacturing organization (CDMO). Based in Germany, Rottendorf is well-known for developing, manufacturing, and packaging formulations for oral solid dosage forms that cater to the pharmaceutical and biotechnology sectors globally. The company's unique foundation-backed ownership and partnership-focused strategy provide them with a distinct edge, fostering long-lasting relationships with their clients.
Reasons Behind the Selection
Rottendorf Pharma’s decision to adopt the ValGenesis VLMS stems from its impressive capacity to streamline and standardize key processes. The intuitive design of VLMS 5.0 enhances user experience, allowing teams to quickly adapt and utilize the system efficiently. Furthermore, ValGenesis’s cost-effective solutions and the high level of support from their dedicated team played a crucial role in securing this partnership. Rottendorf Pharma recognized that ValGenesis VLMS represents a forward-thinking approach with a strong roadmap for enhancements and continued innovation.
A Transformative Partnership
“As a pivotal entity within Germany's pharmaceutical supply chain, Rottendorf Pharma is gearing up for significant changes in manufacturing with ValGenesis VLMS,” states Steve Reynolds, Chief Revenue Officer at ValGenesis. He emphasizes that the selection of their digital validation platform harmonizes seamlessly with Rottendorf’s devotion to quality and efficient drug delivery processes.
The Significance of Digital Solutions
Markus Krellmann, Head of QA Data Quality Compliance at Rottendorf Pharma, echoes the sentiment behind their recent decision. After conducting a meticulous analysis of various software solutions, it became clear that ValGenesis VLMS fit their requirements to perfection. The software not only encompasses the necessary functionalities but also offers advanced technologies that promise enduring value as Rottendorf continues its evolution.
Rottendorf Pharma's Service Philosophy
Rottendorf Pharma operates on key principles that underscore their commitment to customers—namely Total Process Ownership (TPO©), Total Technological Mastering (TTM), and Total Supply Integrity (TSI). These guiding concepts empower Rottendorf Pharma as a CDMO that consistently delivers substantial value to clients by maintaining a customer-first focus.
About ValGenesis Inc.
ValGenesis, Inc. is acclaimed for its groundbreaking software solution that manages compliance-driven validation activities specifically designed for life science companies. As the pioneer of a fully compliant enterprise application that administers corporate validation life cycle processes, ValGenesis has set a benchmark in the industry. Their solutions adhere to crucial regulations such as U.S. FDA 21 CFR Part 11 and Annex 11 and were recognized with the Parenteral Drug Association (PDA) New Innovative Technology Award in 2005 for pioneering the completely paperless solutions for managing validation execution and approval.
Frequently Asked Questions
What is ValGenesis VLMS?
ValGenesis VLMS is an enterprise validation lifecycle management system that helps companies streamline their validation processes digitally.
Why did Rottendorf Pharma choose ValGenesis VLMS?
Rottendorf Pharma selected ValGenesis VLMS due to its ability to align with their specific needs for digitizing validation processes and its cost-effectiveness.
What industries does Rottendorf Pharma serve?
Rottendorf Pharma serves the pharmaceutical and biotechnology industries, providing services for developing and manufacturing oral solid dosage forms.
What are Rottendorf Pharma's key service concepts?
The key service concepts of Rottendorf Pharma include Total Process Ownership (TPO©), Total Technological Mastering (TTM), and Total Supply Integrity (TSI).
What awards has ValGenesis received?
ValGenesis was awarded the Parenteral Drug Association (PDA) New Innovative Technology Award in 2005 for its contributions to validation solutions.
